Kovack Advisors, Inc. - HUMACYTE INC ownership

Back to all holdings Add to watchlist

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Kovack Advisors, Inc. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$123,060
+7.6%
42,000
+5.0%
0.02%
+13.3%
Q2 2023$114,400
+5.8%
40,000
+14.3%
0.02%0.0%
Q1 2023$108,150
+105.0%
35,000
+40.0%
0.02%
+87.5%
Q4 2022$52,750
-76.2%
25,000
-20.6%
0.01%
-65.2%
Q1 2022$222,000–31,500–0.02%–
 Download
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders